StonvexLoading…
StonvexStonvexStonvexCore line items from STZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-28 | Annual 2025 2025-02-28 | Annual 2024 2024-02-29 | Annual 2023 2023-02-28 |
|---|---|---|---|---|
Revenue | $9.14B | $10.21B | $9.96B | $9.45B |
Operating Income | $2.72B | $354.90M | $3.17B | $2.84B |
Net Income | $1.69B | $-81.40M | $1.73B | $-71.00M |
EPS (Diluted) | Not available | Not available | Not available | Not available |
Total Assets | $21.90B | $21.65B | $25.69B | $24.66B |
Total Liabilities | $13.51B | $14.52B | $15.63B | $15.93B |
Cash & Equivalents | $102.40M | $68.10M | $152.40M | $133.50M |
Free Cash Flow OCF − CapEx | $1.79B | $1.94B | $1.51B | $1.72B |
Shares Outstanding | Not available | Not available | Not available | Not available |